CMR College of Pharmacy, Kandlakoya, Medchal, Hyderabad, Telangana, India
A novel Spectrophotometric method for quantifying carbamazepine in pharmaceuticals has been developed and validated per ICH Q2 (R1) guidelines. The maximum absorption wavelength was identified at 285 nm in a 0.1N NaOH solution, with a regression coefficient of 0.999, confirming adherence to Beer's Law within a 2–10 ?g/ml concentration range. Calibration curves demonstrated linearity, and quality control standards showed accuracy, precision, and robustness, with recovery percentages between 99.2% and 100.8%. The method exhibited low relative standard deviation (RSD) values, with intra-day and inter-day precision RSDs of 0.93% to 1.38%. The assay result for carbamazepine in the formulation was 99.5%, validating the method according to ICH standards.
Carbamazepine is chemically related to the tricyclic antidepressants. It is a derivative of iminostilbene with a carbamoyl group at the 5 position; this moiety is essential for potent antiseizure activity [1, 2]. Carbamazepine, 5H di benzo (b, f) azepine-5-carboxamide (fig. 1), is an antiepileptic drug and is the drug of choice for the treatment of grand mal and psychomotor epilepsy. It is considered to be one of the most vital drugs for the relief of pain associated with trigeminal neuralgia [3-4]. It is a white or almost white, crystalline powder, practically insoluble in water, freely soluble in methylene chloride, sparingly soluble in acetone and alcohol, and practically insoluble in ether. It shows polymorphism. Carbamazepine is official in IP, USP, BP, etc [5, 6]. According to the investigation of literature, UV spectro-photometric and HPLC analytical methods were developed at different wavelengths for the analysis of Carbamazepine in plasma fluids, human serum, plasma, and pharmaceutical tablet dosage form or bulk drug sample. [7-11]. The rationale of this work is to develop a simple, accurate, rapid, precise, reproducible, and cost-effective Spectrophotometric method for the direct quantitative determination of carbamazepine. There are several dosage forms of carbamazepine available on the market, including chewable tablets, suspension, sustained-release capsules, and sustained-release tablets [12]. The Beer-Lambert law is the main principle governing Spectrophotometric quantitative analysis [13-15]. Carbamazepine (CBZ) is an anticonvulsant medication used for the treatment of seizures, bipolar disorder, neuropathic pain, neuralgia, and trigeminal. It works by diminishing nerve impulses that cause seizures and pain. The available carbamazepine dosage forms in the market are chewable tablets, suspension, sustained-release capsules, and sustained-release tablets.
Fig 1: Chemical structure of Carbamazepine
MATERIALS AND METHODS
Materials
Carbamazepine (API), Tegreto 200 mg tablets, ethanol, sodium hydroxide and Water HPLC Grade
Instruments
UV-Visible spectrophotometer with UV Win software, Electronic Balance, Biotech’s Ultra Sonicator, pH meter, Water bath shaker, Centrifuge and Refrigerator
METHOD DEVELOPMENT
Preparation of a standard stock solution
A precise quantity of 10 mg of carbamazepine was measured and transferred into a 10 mL volumetric flask. It was then dissolved in a minimal amount of ethanol until complete solubility was achieved. The solution's volume was subsequently adjusted to the calibration mark using 0.1N NaOH, yielding a standard stock solution with a concentration of 1000 ?g/ml. To create a 100 ?g/ml concentration from this initial stock solution, 1 mL was pipetted and moved to a 10 mL volumetric flask, followed by the addition of sodium hydroxide to achieve the final volume, resulting in the preparation of the second standard stock solution.
Selection of wavelength for analysis of carbamazepine
A 10 ml volumetric flask was accurately filled with 1 ml of standard stock solution-2, which was subsequently diluted to a total volume of 10 ml using sodium hydroxide, resulting in a concentration of 10?g/ml. This prepared stock solution was utilized for an initial spectral scan within the UV range of 200-400 nm to identify the maximum wavelength.
Preparation of a sample solution
A precise measurement was taken of ten tablets, and their average weight was determined before they were ground into a fine powder. The powder corresponding to 10 mg of carbamazepine was then dissolved in ethanol with the help of sonication. The solution was adjusted to a total volume of 10 ml in a volumetric flask using sodium hydroxide, resulting in a concentration of 1000 ?g/ml. The amount of carbamazepine in the commercially available formulation (Tegreto 200 mg) was assessed using a pre-validated method.
Fig 2: Absorbance spectrum of carbamazepine
Assay
%Assay =(Sample absorbence)/(Stad.absorbence)×(Weight of standard)/(Dilution of standard)×(Dilution of sample)/(Weight of sample)×Purity/100×(Weight of tab.)/(Label claim)×100
Table 1: Assay of Carbamazepine formulation
Method validation
According to ICH Q2 (R1) and USP criteria, the suggested technique was validated for a number of parameters, including linearity, accuracy, precision, limit of detection (LOD), limit of quantification (LOQ), robustness, ruggedness and stability studies [19-20].
Linearity
Serial dilutions were performed from the standard stock-2 solution to obtain concentrations of 2?g/mL, 4?g/mL, 6?g/mL, 8?g/mL, and 10?g/mL. The absorbance of each concentration was measured at 285 nm. A calibration curve was generated by plotting absorbance on the y-axis and concentration on the x-axis.
Precision
Six replicate measurements were conducted on the homogeneous solution to assess the precision of the method, focusing on both repeatability (intraday precision) and intermediate precision (interday precision) for the reference solution at a concentration of 8?g/mL. To enhance the accuracy of the method, three replicates were introduced into the system on the same day. The results were then calculated as the percentage of the relative standard deviation (RSD).
Accuracy
A recovery study for carbamazepine was conducted at concentrations of 50%, 100%, and 150%. The findings are presented in the table below. It was observed that there were no drug-drug interactions, drug-excipients interactions, or drug-solvent interactions identified. Therefore, it has been confirmed that none of the components interfere with the drug.
LOD and LOQ
The detection limit of an analytical method indicates the smallest amount of an analyte present in a sample that can be recognized, even if it cannot be measured accurately. On the other hand, the quantification limit is the minimum concentration of an analyte that can be measured reliably and with sufficient accuracy in a specific analytical process.
Robustness
The robustness of this procedure was evaluated by measuring the absorbance of a 6?g/mL carbamazepine standard solution at different maximum wavelengths (specifically ±1nm) around the actual maximum.
Ruggedness
The assessment of ruggedness was conducted by analyzing data collected from various analysts, each utilizing different reagents and instruments.
Stability
Stability of carbamazepine sample solution was determined initially and 24 hours later, the % assay was compared.
RESULTS AND DISCUSSION
Linearity
The range of the linearity concentration for carbamazepine was 2–10 ?g/mL shown in Table 2. Fig 3 displayed the calibration curve and the calculation of the correlation coefficient, intercept, and slope of carbamazepine.
Table.2. Linearity of carbamazepine at 285 nm & Statistical Data
Fig 3: Calibration curve of carbamazepine at 285 nm
Precision
The precision study showed no significant differences in precision values, confirming the method's suitability for analyzing carbamazepine in tablet formulations. There was no evidence of interference from excipients. Results ranged from 98.33% to 100.56%, with an acceptable deviation of 2%.
Table.3. Precision data of carbamazepine
LOD and LOQ
The LOD (Limit of Detection) was estimated from the set of 6 calibration curves used to determine method linearity. The LOD may be calculated as
LOD = 3.3 × (S.D./Slope)
Where,
SD = Standard deviation of the Y- intercepts of the 6 calibration curves
Slope = Mean slope of the 6 calibration curves
The LOQ (Limit of Quantization) was estimated from the set of 6 calibration curves used to determine method linearity.
The LOQ may be The LOQ may be calculated as
LOQ = 10 × (S.D./Slope)
Where SD = Standard deviation of the Y- intercepts of the 6 calibration curves
Slope = Mean slope of the 6 calibration curves
Table: 4. LOD and LOQ results of Carbamazepine
Ruggedness
The assessment of ruggedness was conducted by analyzing data collected from various analysts, each utilizing different reagents and instruments. Each analyst prepared six samples from the same batch, and the resulting data is presented in the table.
Table.5.Ruggedness of Carbamazepine
Accuracy (Recovery studies)
Recovery study for carbamazepine was carried out at 50%, 100%, and 150% concentration. The results were shown in the table using the data below. Drug-drug interaction, drug excipients interaction, and drug solvent interaction have not been noticed or identified. Hence, it has been proved that there is no interference of any component with the drug.
Table.6. Recovery studies of carbamazepine
Robustness
The robustness of this procedure was evaluated by measuring the absorbance of a 6?g/mL carbamazepine standard solution at different maximum wavelengths (specifically ±1nm) around the actual maximum.
Table.7. Robustness data of carbamazepine
Stability Studies
To check the stability of the solution, a sample solution of carbamazepine with a concentration of 6?g/mL was taken. In table 8, stability studies information was displayed
CONCLUSION:
The developed UV- Spectroscopy method for the estimation of carbamazepine was found to be simple, precise, accurate, robust, economical, and rapid, making it more acceptable and cost-effective. It can also be successfully
REFERENCE
Banothu Bhadru , Tadikonda Rama Rao, Arukala Bhavani, Stability Indicating Analytical Method Development And Validation Of Carbamazepine Using UV Spectroscopy, Int. J. of Pharm. Sci., 2024, Vol 2, Issue 9, 1374-1380. https://doi.org/10.5281/zenodo.13851427